NCT03458728 2023-12-04Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric PatientsBayerPhase 1/2 Terminated31 enrolled 17 charts
NCT03886649 2022-04-01Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.Swiss Cancer InstitutePhase 1 Terminated7 enrolled